[Probable stenocardial effects of combined oral contraceptives].
One case of myocardial infarction and one case of coronary insufficiency, observed in women treated with oral contraceptives, are presented. Pathogenetic hypotheses are put forward and stress is laid on the necessity of evaluating risk factors as well as carrying out the various hemogenic tests in these patients.
D000249:Adenosine Monophosphate / Q000627:therapeutic use; D000328:Adult; D000787:Angina Pectoris / Q000139:chemically induced* / Q000175:diagnosis; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D004983:Ethanolamines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010417:Pentaerythritol Tetranitrate / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000175:diagnosis / Q000188:drug therapy; D013831:Thiamine / Q000627:therapeutic use; D014805:Vitamin B 12 / Q000627:therapeutic use
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D004983:Ethanolamines; D010417:Pentaerythritol Tetranitrate; D000249:Adenosine Monophosphate; C020283:diethanolamine; D014805:Vitamin B 12; D013831:Thiamine
Probabili effetti stenocardici dei contraccettivi orali di tipo combinato.